Skip to main content

Table 2 Impact of Diabetic-related Co-morbid Conditions on Treatment Satisfaction

From: Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues

  ITSQ Overall (n = 197) ITSQ IR (n = 196) ITSQ LF (n = 196) ITSQ HC (n = 197) ITSQ GC (n = 197) ITSQ DD (n = 197)
  Coefficient (t-ratio)
Intercept 84.11*** (56.89) 87.24*** (51.36) 78.85*** (41.72) 81.75*** (42.67) 86.43*** (49.64) 84.79*** (54.58)
Retinopathy (N = 0, Y = 1) 7.29 (1.50) 8.94 (1.60) 0.95 (0.15) 2.31 (0.37) 10.17 (1.78) 10.90* (2.13)
Nephropathy (N = 0, Y = 1) 2.08 (0.40) -0.61 (-0.10) 3.68 (0.55) 3.79 (0.56) -2.57 (-0.42) 3.94 (0.71)
Neuropathy (N = 0, Y = 1) -10.56*** (-3.53) -8.81* (-2.54) -12.42** (-3.22) -10.80** (-2.79) -13.43*** (-3.82) -8.00* (-2.54)
Macro Angiopathy (N = 0, Y = 1) -5.18 (-1.09) -1.16 (-0.21) -4.58 (-0.76) -5.63 (-0.92) -5.93 (-1.06) -6.44 (-1.29)
  F = 3.622** F = 1.888 F = 2.943* F = 2.280 F = 4.281** F = 2.789*
  R2 = 0.069 R2 = 0.037 R2 = 0.057 R2 = 0.044 R2 = 0.080 R2 = 0.054
  Adj R2 = 0.050 Adj R2 = -0.018 Adj R2 = 0.038 Adj R2 = 0.025 Adj R2 = 0.062 Adj R2 = -0.035
  1. • * p < 0.05, ** p < 0.01, *** p < 0.001
  2. • IR = Inconvenience of Regime subscale, LF = Lifestyle Flexibility subscale, HC = Hypoglycemic Control subscale, GC = Glycemic Control subscale, DD = Device Delivery subscale